中国循证医学杂志

中国循证医学杂志

试验序贯分析检验 Cochrane 泌尿外科学小组 Meta 分析假阳性结果的研究

查看全文

目的 采用试验序贯分析(TSA)检验 Cochrane 泌尿外科学小组累积 Meta 分析假阳性结果。 方法 计算机检索 The Cochrane Library(2016 年第 6 期)“Urology Group”的系统评价,查找具有阳性结果的 Meta 分析。由 2 位研究者独立进行文献筛选和资料提取,然后采用 TSA 0.9β 软件进行 TSA。 结果 共纳入 11 个 Meta 分析。TSA 结果显示,11 个 Meta 分析中,有 8 个(72.7%)Meta 分析的结论既未穿过 TSA 界值,也未达到期望信息量,为潜在的假阳性结果。 结论 TSA 可以辅助判断 Meta 分析的结果是否为假阳性结果。

Objective To detect the false-positive results of cumulative meta-analyses of Cochrane Urology Group with the trial sequential analysis (TSA). Methods The systematic reviews of Urology Group of The Cochrane Library were searched to collect meta-analyses with positive results. Two researchers independently screened literature and extracted data of included meta-analyses. Then, TSA was performed using TSA software version 0.9 beta. Results A total of 11 meta-analyses were included. The results of TSA showed that, 8 of 11 (72.7%) meta-analyses were potentially false-positive results for failing to surpass the trial sequential monitoring boundary and to reach the required information size. Conclusion TSA can help researchers to identify the false-positive results of meta-analyses.

关键词: 试验序贯分析; Meta 分析; 假阳性; Cochrane 系统评价

Key words: Trial sequential analysis; Meta-analysis; False-positive; Cochrane systematic review

引用本文: 翁鸿, 王朝阳, 贺大林, 李胜, 彭双鹤, 曾宪涛. 试验序贯分析检验 Cochrane 泌尿外科学小组 Meta 分析假阳性结果的研究. 中国循证医学杂志, 2017, 17(4): 458-462. doi: 10.7507/1672-2531.201607064 复制

登录后 ,请手动点击刷新查看全文内容。 没有账号,
登录后 ,请手动点击刷新查看图表内容。 没有账号,
1. 曾宪涛, 邝心颖, 孙燕, 等. 什么是循证医学?. 湖北医药学院学报, 2013, 32(1): 1-5.
2. 曾宪涛, 冷卫东, 郭毅, 等. Meta 分析系列之一: Meta 分析的类型. 中国循证心血管医学杂志, 2012, 4(1): 3-5.
3. Borm GF, Donders AR. Updating meta-analyses leads to larger type I errors than publication bias. J Clin Epidemiol, 2009, 62(8): 825-830.
4. Pogue JM, Yusuf S. Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis. Control Clin Trials, 1997, 18(6): 580-593.
5. Wetterslev J, Thorlund K, Brok J, et al. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol, 2008, 61(1): 64-75.
6. Brok J, Thorlund K, Gluud C, et al. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. J Clin Epidemiol, 2008, 61(8): 763-769.
7. Thorlund K, Devereaux PJ, Wetterslev J, et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? Int J Epidemiol, 2009, 38(1): 276-286.
8. Wetterslev J, Thorlund K, Brok J, et al. Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Med Res Methodol, 2009, 9(1): 1-12.
9. Thorlund K, Engstrøm J, Wetterslev J, et al. User manual for trial sequential analysis (TSA). Copenhagen Trial Unit, Center for Clinical Intervention Research, Copenhagen, Denmark. 2011. Available at: .
10. Wilt TJ, Ishani A. Pygeum africanum for benign prostatic hyperplasia. Cochrane Database Syst Rev, 1998, (1): CD001044.
11. Schmitt B, Bennett C, Seidenfeld J, et al. Maximal androgen blockade for advanced prostate cancer. Cochrane Database Syst Rev, 1999, (4): CD001526.
12. Hoffman RM, MacDonald R, Wilt TJ. Laser prostatectomy for benign prostatic obstruction. Cochrane Database Syst Rev, 2000, (1): CD001987.
13. Shelley MD, Court JB, Kynaston H, et al. Intravesical bacillus Calmette-Guerin in Ta and T1 bladder cancer. Cochrane Database Syst Rev, 2000, (4): CD001986.
14. Kumar S, Shelley M, Harrison C, et al. Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer. Cochrane Database Syst Rev, 2006, (4): CD006019.
15. Melnik T, Soares BG, Nasselo AG. Psychosocial interventions for erectile dysfunction. Cochrane Database Syst Rev, 2007, (3): CD004825.
16. Wilt TJ, MacDonald R, Hagerty K, et al. 5-alpha-reductase inhibitors for prostate cancer prevention. Cochrane Database Syst Rev, 2008, (2): CD007091.
17. Shang PF, Kwong J, Wang ZP, et al. Intravesical Bacillus Calmette-Guerin versus epirubicin for Ta and T1 bladder cancer. Cochrane Database Syst Rev, 2011, (5): CD006885.
18. Zani EL, Clark OA, Rodrigues Netto Jr N. Antibiotic prophylaxis for transrectal prostate biopsy. Cochrane Database Syst Rev, 2011, (5): CD006576.
19. Hoffman RM, Monga M, Elliott SP, et al. Microwave thermotherapy for benign prostatic hyperplasia. Cochrane Database Syst Rev, 2012, (9): CD004135.
20. Kunath F, Grobe HR, Rucker G, et al. Non-steroidal antiandrogen monotherapy compared with luteinising hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer. Cochrane Database Syst Rev, 2014, (6): CD009266.
21. 曾宪涛, 冷卫东, 李胜, 等. 如何正确理解及使用 GRADE 系统. 中国循证医学杂志, 2011, 11(9): 985-990.
22. 陈耀龙, 杨克虎, 姚亮, 等. GRADE 系统方法学进展. 中国循证儿科杂志, 2013, 8(1): 64-65.
23. 陈耀龙, 姚亮, Susan Norris, 等. GRADE 在系统评价中应用的必要性及注意事项. 中国循证医学杂志, 2013, 13(12): 1401-1404.
24. Gordon H. Guyatt, Andrew D. Oxman, Regina Kunz, 等. GRADE 指南: Ⅵ.证据质量评价—不精确性(随机误差). 中国循证医学杂志, 2011, 11(12): 1435-1443.